Cinda Biotech rose more than 10% to HK$112.70 in the intraday market, a record high. The company previously announced a 45% year-on-year increase in revenue for the first half of the year to RMB 8.6 billion. Although total revenue fell short of estimates, Nomura said net profit growth exceeded expectations.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.